ONS Connections: Neck disability and depressive symptoms linked in patients with head and neck cancer

Share this content:
PHOENIX—Neck disability and depressive scores were significantly correlated among patients with head and neck cancer, according to research that was reported at the Oncology Nursing Society (ONS) Connections: Advancing Care Through Science conference.

Approximately 50,000 individuals are affected by head and neck cancer annually, which accounts for 3% of all cancers in the United States. Oncology nurses need to be familiar with common symptoms that these patients experience in order to provide holistic care.

This study assessed 31 patients with head and neck cancer at baseline, immediately after treatment, and at 6 and 12 weeks post-treatment. The enrolled patients were predominantly male (75%, n=23), Caucasian (84%, n=26), married (68%, n=21), smokers at the time of diagnosis (81%, n=25), and used alcohol at some level (65%, n=20).

Between the four assessment time points, significant changes occurred in pain intensity, ability to work, and sleeping. Between the end of treatment and 12 weeks post-treatment, depression scores significantly decreased (P=.007, Z= -2.679). The composite neck disability index scores and depressive scale scores were significantly correlated at all time points.

Psychological distress significantly decreased in the three months after treatment for head and neck cancer ended. This population of head and neck cancer patients had associations between neck-related function and psychological distress. The psychological distress of these patients was influenced by pain, ability to work, and sleeping.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs